Bacitracin (Akorn, Inc.)
Welcome to the PulseAid listing for the Bacitracin drug offered from Akorn, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Akorn, Inc. |
NON-PROPRIETARY NAME: | Bacitracin |
SUBSTANCE NAME: | BACITRACIN A |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | |
ROUTE: | INTRAMUSCULAR |
DOSAGE FORM: | INJECTION, POWDER, FOR SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-10-23 |
END MARKETING DATE: | 0000-00-00 |
Bacitracin HUMAN PRESCRIPTION DRUG Details:
Item Description | Bacitracin from Akorn, Inc. |
LABELER NAME: | Akorn, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5000([USP’U]/mL) |
START MARKETING DATE: | 2017-10-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17478-608_bb0e2e1d-ff83-43ed-a9be-4339d1226f32 |
PRODUCT NDC: | 17478-608 |
APPLICATION NUMBER: | ANDA206719 |
Other BACITRACIN A Pharmaceutical Manufacturers / Labelers: